Compile Data Set for Download or QSAR
maximum 50k data
Found 25 of ph data with Target = 'Cathepsin L2'
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM31972(Dipeptidyl nitrile inhibitor, 5)
Affinity DataIC50:  398nMpH: 7.0 T: 2°CAssay Description:IC50 values for inhibition of Cathepsins were determined from dose dependent inhibition of cleavage of fluorogenic, AMC-tagged, peptide substrates.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM31975(Dipeptidyl nitrile inhibitor, 8)
Affinity DataIC50:  794nMpH: 7.0 T: 2°CAssay Description:IC50 values for inhibition of Cathepsins were determined from dose dependent inhibition of cleavage of fluorogenic, AMC-tagged, peptide substrates.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM31970(Dipeptidyl nitrile inhibitor, 1)
Affinity DataIC50:  794nMpH: 7.0 T: 2°CAssay Description:IC50 values for inhibition of Cathepsins were determined from dose dependent inhibition of cleavage of fluorogenic, AMC-tagged, peptide substrates.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93444(Flavonid, 6[3,1])
Affinity DataIC50:  800nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM31974(Dipeptidyl nitrile inhibitor, 7)
Affinity DataIC50:  1.00E+3nMpH: 7.0 T: 2°CAssay Description:IC50 values for inhibition of Cathepsins were determined from dose dependent inhibition of cleavage of fluorogenic, AMC-tagged, peptide substrates.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93438(Flavonid, 6d)
Affinity DataIC50:  1.20E+3nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93445(Flavonid, 6[3,2])
Affinity DataIC50:  1.60E+3nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93451(Flavonid, 6[1,4])
Affinity DataIC50:  2.70E+3nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93447(Flavonid, 6[3,6])
Affinity DataIC50:  2.90E+3nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93446(Flavonid, 6[3,3])
Affinity DataIC50:  4.10E+3nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM31973(Dipeptidyl nitrile inhibitor, 6)
Affinity DataIC50:  6.31E+3nMpH: 7.0 T: 2°CAssay Description:IC50 values for inhibition of Cathepsins were determined from dose dependent inhibition of cleavage of fluorogenic, AMC-tagged, peptide substrates.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM31971(Dipeptidyl nitrile inhibitor, 4)
Affinity DataIC50:  6.31E+3nMpH: 7.0 T: 2°CAssay Description:IC50 values for inhibition of Cathepsins were determined from dose dependent inhibition of cleavage of fluorogenic, AMC-tagged, peptide substrates.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93440(Flavonid, 6[1,6])
Affinity DataIC50:  1.11E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM49933(6-methoxy-2-(4-methoxyphenyl)-1-benzopyran-4-one |...)
Affinity DataIC50:  1.20E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93441(Flavonid, 6[2,2])
Affinity DataIC50:  1.90E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93450(Flavonid, 6[4,6])
Affinity DataIC50:  1.92E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93439(Flavonid, 6e)
Affinity DataIC50: >5.00E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93434(Flavonid, 5a)
Affinity DataIC50: >5.00E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93448(Flavonid, 6[4,2])
Affinity DataIC50: >5.00E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93449(Flavonid, 6[4,3])
Affinity DataIC50: >5.00E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93436(Flavonid, 5c)
Affinity DataIC50: >5.00E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93443(Flavonid, 6[2,6])
Affinity DataIC50: >5.00E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93442(Flavonid, 6[2,3])
Affinity DataIC50: >5.00E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93437(Flavonid, 6b)
Affinity DataIC50: >5.00E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM93435(Flavonid, 5b)
Affinity DataIC50: >5.00E+4nMpH: 5.5 T: 2°CAssay Description:Recombinant human cathepsin V was expressed and purified as described previously.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed